Skip to main content
A

Abnova (Taiwan) Corporation — Investor Relations & Filings

Ticker · 4133 TW Professional, scientific and technical activities
Filings indexed 1,472 across all filing types
Latest filing 2026-02-25 Regulatory Filings
Country TW Taiwan
Listing TW 4133

About Abnova (Taiwan) Corporation

http://www.abnova.com

Abnova Corporation is a global leader in the high-throughput production of antibodies and recombinant proteins. By integrating industrial-scale manufacturing with IT-driven management systems, the company maintains one of the world's largest catalogs of biological reagents. Its core offerings encompass gene synthesis, cytogenetics, peptide services, and protein expression. Abnova provides comprehensive solutions for life science research, including custom antibody production, scale-up, and humanization. Recent technological expansions include the RNAutomation™ mRNA service, NanoAb™ services, and nanoCAR-T mRNA solutions. The company supports academic and industrial researchers across multidisciplinary fields with integrated assay development and advanced bioreagent tools.

Recent filings

Filing Released Lang Actions
公告本公司董事會決議召開115年股東常會事宜
Regulatory Filings
2026-02-25 Chinese
公告本公司董事會通過114年度財務報告
Regulatory Filings
2026-02-25 Chinese
公告本公司董事會決議股利分派
Regulatory Filings
2026-02-25 Chinese
公告本公司董事會決議通過不發放114年度員工酬勞及董事酬勞
Regulatory Filings
2026-02-25 Chinese
114年度股利金額(董事會決議)
Regulatory Filings
2026-02-25 Chinese
公司基本資料
Regulatory Filings
2026-02-25 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.